Latin America Artificial Intelligence In Drug Discovery Market Size & Outlook
Related Markets
Latin America artificial intelligence in drug discovery market highlights
- The Latin America artificial intelligence in drug discovery market generated a revenue of USD 26.9 million in 2023.
- The market is expected to grow at a CAGR of 28.9% from 2024 to 2030.
- In terms of segment, oncology was the largest revenue generating therapeutic space in 2023.
- Infectious Disease is the most lucrative therapeutic space segment registering the fastest growth during the forecast period.
- Country-wise, Argentina is expected to register the highest CAGR from 2024 to 2030.
Latin America data book summary
| Market revenue in 2023 | USD 26.9 million |
| Market revenue in 2030 | USD 158.9 million |
| Growth rate | 28.9% (CAGR from 2024 to 2030) |
| Largest segment | Oncology |
| Fastest growing segment | Infectious Disease |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases, Infectious Disease, Other |
Other key industry trends
- In terms of revenue, Latin America region accounted for 1.8% of the global artificial intelligence in drug discovery market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,165.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Artificial Intelligence in Drug Discovery Market Scope
Artificial Intelligence in Drug Discovery Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Insitro | View profile | 101-250 | South San Francisco, California, United States, North America | http://www.insitro.com |
| Atomwise | View profile | 51-100 | San Francisco, California, United States, North America | http://www.atomwise.com |
| BioSymetrics | View profile | 11-50 | New York, New York, United States, North America | http://www.biosymetrics.com |
| Recursion Pharmaceuticals Inc Class A | View profile | 500 | 41 S Rio Grande Street, Salt Lake City,, UT, United States, 84101 | https://www.recursion.com |
| Benevolent AI | View profile | 248 | 4-8 Maple Street, London, United Kingdom, W1T 5HD | https://www.benevolent.com |
| Aitia | View profile | 51-100 | Somerville, Massachusetts, United States, North America | https://www.aitiabio.com/ |
| Insilico Medicine | View profile | 101-250 | Hong Kong, Hong Kong Island, Hong Kong, Asia | http://www.insilico.com |
| Exscientia PLC ADR | View profile | 483 | Oxford Science Park, The Schrodinger Building, Oxford, United Kingdom, OX4 4GE | https://www.exscientia.ai |
| Alphabet Inc Class A | View profile | 180895 | 1600 Amphitheatre Parkway, Mountain View, CA, United States, 94043 | https://www.abc.xyz |
| International Business Machines Corp | View profile | 282200 | One New Orchard Road, Armonk, NY, United States, 10504 | http://www.ibm.com |
Latin America artificial intelligence in drug discovery market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in drug discovery market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 22.3% in 2023. Horizon Databook has segmented the Latin America artificial intelligence in drug discovery market based on oncology, neurodegenerative diseases, cardiovascular disease, metabolic diseases, infectious disease, other covering the revenue growth of each sub-segment from 2018 to 2030.
Latin America is expected to be a potential market for AI in healthcare, owing to government readiness for adopting newer technology. According to a survey by International Development Research Centre (IDRC) and Oxford Insights, the governments of Uruguay, Mexico, and Brazil were ranked among the top 50 countries for readiness to adopt AI.
Moreover, integration of AI and machine learning methods into drug discovery pipelines is offering lucrative opportunities to the region by supporting in cutting down cost & time and improving R&D efficiency. This is anticipated to drive its adoption in the region, which can contribute positively to the overall market growth.
Reasons to subscribe to Latin America artificial intelligence in drug discovery market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Latin America artificial intelligence in drug discovery market databook
-
Our clientele includes a mix of artificial intelligence in drug discovery market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America artificial intelligence in drug discovery market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America artificial intelligence in drug discovery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Latin America artificial intelligence in drug discovery market size, by country, 2018-2030 (US$M)
Latin America Artificial Intelligence in Drug Discovery Market Outlook Share, 2023 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
